Ark Therapeutics  (LON:AKT)

Ark Therapeutics (LON:AKT)


Share Price
0
Change
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Ark Therapeutics

Ark Therapeutics Group plc is an innovative gene-based medicine company with operations in the UK and Finland.  Ark seeks to capitalise on its pipeline of programmes in high value areas of unmet medical need within vascular disease and cancer, all of which have originated in its two world-leading research centres in Kuopio and London.
EPIC: AKT
Market: AIM:AKT
Sector: Pharma & Biotech
Website: www.arktherapeutics.com
col 3
col 4
col 5
col 6

Columns Including AKT

VIEW ALL

Market Reports Including AKT

VIEW ALL

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use